Assessing the association between dipeptidyl peptidase-4 inhibitors use and celiac disease through drug adverse event reporting.
Publication
, Journal Article
Li, D; Silvester, JA; Crowley, MJ; Yang, JY; Alexopoulos, A-S; Xu, Y; Zhan, S; Wang, T
Published in: Ther Adv Chronic Dis
2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Ther Adv Chronic Dis
DOI
ISSN
2040-6223
Publication Date
2020
Volume
11
Start / End Page
2040622320904301
Location
United States
Related Subject Headings
- 4203 Health services and systems
- 3214 Pharmacology and pharmaceutical sciences
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Li, D., Silvester, J. A., Crowley, M. J., Yang, J. Y., Alexopoulos, A.-S., Xu, Y., … Wang, T. (2020). Assessing the association between dipeptidyl peptidase-4 inhibitors use and celiac disease through drug adverse event reporting. Ther Adv Chronic Dis, 11, 2040622320904301. https://doi.org/10.1177/2040622320904301
Li, Dandan, Jocelyn Anne Silvester, Matthew J. Crowley, Jeff Y. Yang, Anastasia-Stefania Alexopoulos, Yang Xu, Siyan Zhan, and Tiansheng Wang. “Assessing the association between dipeptidyl peptidase-4 inhibitors use and celiac disease through drug adverse event reporting.” Ther Adv Chronic Dis 11 (2020): 2040622320904301. https://doi.org/10.1177/2040622320904301.
Li D, Silvester JA, Crowley MJ, Yang JY, Alexopoulos A-S, Xu Y, et al. Assessing the association between dipeptidyl peptidase-4 inhibitors use and celiac disease through drug adverse event reporting. Ther Adv Chronic Dis. 2020;11:2040622320904301.
Li, Dandan, et al. “Assessing the association between dipeptidyl peptidase-4 inhibitors use and celiac disease through drug adverse event reporting.” Ther Adv Chronic Dis, vol. 11, 2020, p. 2040622320904301. Pubmed, doi:10.1177/2040622320904301.
Li D, Silvester JA, Crowley MJ, Yang JY, Alexopoulos A-S, Xu Y, Zhan S, Wang T. Assessing the association between dipeptidyl peptidase-4 inhibitors use and celiac disease through drug adverse event reporting. Ther Adv Chronic Dis. 2020;11:2040622320904301.
Published In
Ther Adv Chronic Dis
DOI
ISSN
2040-6223
Publication Date
2020
Volume
11
Start / End Page
2040622320904301
Location
United States
Related Subject Headings
- 4203 Health services and systems
- 3214 Pharmacology and pharmaceutical sciences
- 3202 Clinical sciences